5 Healthcare Stocks with Insider Buying

2. Royalty Pharma plc (NASDAQ:RPRX)

Number of Hedge Fund Holders: 31

US-based Royalty Pharma plc (NASDAQ:RPRX)’s CEO Pablo Legorreta in May bought about $7.7 million worth of RPRX shares at $33.38 per share. The executive continued to amass Royalty Pharma plc (NASDAQ:RPRX)’s shares in June too, with the latest insider buying transaction coming in late June when he bought 130,000 shares of the company. As of August 9 Royalty Pharma plc (NASDAQ:RPRX) is trading at $30.55.

As of the end of the first quarter of 2023, 31 hedge funds tracked by Insider Monkey reported owning stakes in Royalty Pharma plc (NASDAQ:RPRX). The biggest stakeholder of Royalty Pharma plc (NASDAQ:RPRX) during this period was Andreas Halvorsen’s Viking Global which owns a $404 million stake in the company.